These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. Namasivayam S; Zimmerman M; Oland S; Wang H; Mittereder LR; Dartois V; Sher A mBio; 2023 Apr; 14(2):e0035323. PubMed ID: 36877010 [TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis. Almeida D; Nuermberger E; Tasneen R; Rosenthal I; Tyagi S; Williams K; Peloquin C; Grosset J Antimicrob Agents Chemother; 2009 Oct; 53(10):4178-84. PubMed ID: 19620331 [TBL] [Abstract][Full Text] [Related]
6. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model. Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711 [TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383 [TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against Negi S; Pahari S; Bashir H; Agrewala JN Front Immunol; 2019; 10():1142. PubMed ID: 31231363 [TBL] [Abstract][Full Text] [Related]
9. A human xenobiotic nuclear receptor contributes to nonresponsiveness of Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328 [No Abstract] [Full Text] [Related]
10. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
11. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran. Nasiri MJ; Zamani S; Pormohammad A; Feizabadi MM; Aslani HR; Amin M; Halabian R; Imani Fooladi AA Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):9-14. PubMed ID: 28823010 [TBL] [Abstract][Full Text] [Related]
12. Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice. Zhang M; Li SY; Rosenthal IM; Almeida DV; Ahmad Z; Converse PJ; Peloquin CA; Nuermberger EL; Grosset JH Am J Respir Crit Care Med; 2011 May; 183(9):1254-61. PubMed ID: 21330452 [TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice. Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878 [TBL] [Abstract][Full Text] [Related]
14. Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V Front Immunol; 2018; 9():438. PubMed ID: 29593716 [TBL] [Abstract][Full Text] [Related]
15. Retrospective Diagnostic Accuracy Study of Abbott RealTi Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811 [TBL] [Abstract][Full Text] [Related]
16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens. Hofmann-Thiel S; Molodtsov N; Antonenka U; Hoffmann H J Clin Microbiol; 2016 Dec; 54(12):3022-3027. PubMed ID: 27733630 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy. de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361 [TBL] [Abstract][Full Text] [Related]
20. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]. Grosset J; Truffot C; Fermanian J; Lecoeur H Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]